Welcome to Multibagg AI
Log in to access personalized features
Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Research powered by GOALZEN CAPITAL SERVICES PRIVATE LIMITED · SEBI Research Analyst INH000013448
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
iSERA Lifesciences secured 100% shareholder approval to amend preferential issue disclosures, fix an allotment typo, and publish post-issue holdings tied to its share-swap acquisition plan.
Emerald Leisures will meet on Oct 1, 2026 to consider raising funds via equity, warrants or other securities, after filing an update with BSE on Sept 23.
Moneyview IPO chatter centres on the 98.46x subscription, heavy QIB and NII participation, and grey-market signals pointing to a ₹47-₹48 listing zone versus ₹34 issue price.
MTNL’s board approved a G2G sale of its Powai, Mumbai land to the Income Tax Department for ₹891.53 crore, updating earlier ₹900 crore reports.
Sterlite Technologies reported Q1FY27 revenue of ₹1,910 crore and net profit of ₹197 crore, backed by a record ₹18,618 crore order book and new hyperscaler deals.
Moneyview IPO saw 98.46x subscription and active grey-market chatter, with allotment due Sep 29 and an implied listing price near Rs 46.75-48.
Sindhu Trade Links received NSE and BSE listing approvals for 30,04,55,030 preferential shares issued via share swap at ₹23.20, pending NSDL and CDSL credit confirmation.
Morepen Labs is trending after a sharp rally to the ₹125 zone, with social chatter split between “Buy” calls, overbought RSI signals, and mixed profitability trends.
Prabhhans Industries reported standalone June 2026 net sales of ₹10.38 crore, down 52.2% year-on-year, alongside BSE filings on AGM notice publication and e-voting details.
Arambhveer Limited has announced a mandatory open offer to buy up to 26% of Mapro Industries at ₹60.13 per share, with the DPS due by October 1, 2026.
Fosun Pharma sold 9.897 million Gland Pharma shares on September 4, 2026 for about Rs 2,800 crore, reducing its holding to 45.76% while staying the controlling shareholder.
Bliss GVS Pharma recorded a promoter reclassification after Anupam Rasayan and its PAC raised their holding to 50.07% via an SPA, open offer, and on-market purchases.
SEPC said a 30 September 2026 Madras High Court order settled execution petitions worth ₹149.5 crore, lifting interim attachments on ₹154 crore receivables and removing banking restrictions.
Social media is tracking two major brand valuation reports, with Kantar BrandZ and Brand Finance both showing higher aggregate brand values and shifting leaders across rankings.
Kotak Mahindra Bank said the RBI approved Anup Kumar Saha as MD and CEO from January 1, 2027, for three years, succeeding Ashok Vaswani.
Social posts cite a ₹1,300 one-year target for Waaree Renewable Technologies, but the shared material shows only a single analyst point estimate and no 2027 target.
